This firm-fixed-price purchase order was awarded by the Defense Health Agency, a component of the Department of Defense, to Allergychoices LLC, a for-profit small disadvantaged business, to provide 140 units of inhalant multi-allergen for $16,726.48. The award has an ultimate completion date of November 15, 2025. This contract is not associated with a set-aside program. The original sole-source solicitation was issued by the Naval Medical Center San Diego, with the objective of procuring allergy...
The Defense Logistics Agency Troop Support Medical awarded a $1,973.37 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 tablets of Grastek, a sublingual grass pollen tablet allergy immunotherapy. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The single day order runs from August 24 through August 25, 2023. Amerisourcebergen Drug Corporation is a division of Amerisourcebergen Corporation, which will perform as the prime...
This is a firm-fixed-price Blanket Purchase Agreement (BPA) call order awarded by the U.S. Army Medical Command (MEDCOM) to Phadia US Inc., a subsidiary of Thermo Fisher Scientific, for $600,000.00. The BPA call is for allergy and asthma testing solutions, including analyzers, reagents, and consumables to support military medical readiness and research programs. Phadia US Inc. has been the sole source provider for many similar MEDCOM contracts due to its proprietary products being the only...
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $791 to Amerisourcebergen Drug Corporation for allergy medication to be delivered to a location in Conshohocken, Pennsylvania. As a major division of Amerisourcebergen Corporation, Amerisourcebergen Drug Corporation will supply 4561683252 CHLD ALLEGRA ALLERGY 30 MG/5 120ML under the terms of the order from August 2 to August 3, 2023. No set aside designation or subcontracting details were provided. The...
The Defense Logistics Agency awarded a $2,890 delivery order to Amerisourcebergen Drug Corporation for 1000 boxes of 4 mg Aller-Chlor tablets. The firm fixed price order is being fulfilled from Amerisourcebergen's Conshohocken, Pennsylvania location and runs from August 11-14, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for a common allergy medication supports the Defense Logistics Agency's mission to provide critical logistics...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $10,616.40 purchase order contract to Stemcell Technologies Inc. for cell lines. As the prime contractor, Stemcell Technologies will deliver cell lines to NIH/NIAID under the firm fixed price contract. Performance will take place in Kent, Washington over a one-year period from August 2023 through August 2024. No subcontractors or set aside designations were...
The Defense Logistics Agency awarded a $2,880 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1,000 boxes of 4mg Aller-Chlor tablets. The one-day contract has a period of performance from August 14 to August 15, 2023, with all work to be conducted by Amerisourcebergen at its facility in Conshohocken, Pennsylvania. As a major supplier of pharmaceuticals to the Department of Defense, Amerisourcebergen likely fulfilled this short-term requirement for allergy medication...
The Defense Logistics Agency Troop Support Medical awarded a $30,948 delivery order to DMS Pharmaceutical Group Inc. to supply 150 mg/ml syringes of Xolair, an injectable medication used to treat allergic asthma and chronic idiopathic urticaria. The firm fixed price order is under the agency's Prime Vendor Program and has a period of performance from June 26 to July 18, 2023 for delivery to a location in Park Ridge, Illinois. No set aside designation or subcontracting details were provided. This...
The Defense Logistics Agency awarded a $38,685 firm fixed price delivery order to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. The order is for 4562548650 units of XOLAIR 150 MG/ML SYRINGEML, to be delivered by November 9, 2023. XOLAIR is used to treat allergic asthma and chronic idiopathic urticaria. No set-aside designation was used for this award placed under an unidentified indefinite-delivery/indefinite-quantity contract vehicle. DMS Pharmaceutical Group will fulfill the order...
This is a firm-fixed price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Aimmune Therapeutics, Inc., a biopharmaceutical company based in California. The contract is for the company's flagship product, Palforzia, an oral immunotherapy indicated to reduce the severity of allergic reactions to peanuts in children and adolescents. The $13,099.50 award is part of Aimmune's broader Pharmaceuticals and Drugs Federal Supply Schedule contract and...